| 名稱 | β-thalassemia mutation Reference Standard Ⅱ |
| 型號 | CBPD0002 |
| 報價 |  |
| 特點 | β-thalassemia mutation Reference Standard Ⅱ |
產(chǎn)品搜索
相關(guān)文章
聯(lián)系我們
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > 地中海貧血標(biāo)準(zhǔn)品 > CBPD0002β-thalassemia mutation Reference Standard Ⅱ
- 詳細內(nèi)容
| Introduction | |
| Format | Genomic DNA |
| Description | β-thalassemia (β-mediterraneananemia) refers to the A group of hemoglobinopathies in which synthesis is partially or completely inhibited. |
| Technical Data | |
| Variation site | IVS-I-110(G>A) |
| DNA Change | c.93-21G>A |
| Zygosity | Homozygous |
| Allelic Frequency | 100% |
| Transcript | NM_000518.5 |
| Chr position(GRCh37) | Chr11:5248050C>T |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purofication | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
Figure 1. IVS-I-110(G>A) Homozygous |
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
